Search results
Results from the WOW.Com Content Network
C.H. Boehringer Sohn AG & Co. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer (1861–1939) in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world's largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates ...
Merial is now owned by Boehringer Ingelheim and combined with their animal health business, Boehringer Ingelheim Vetmedica, to form Boehringer Ingelheim Animal Health. Merial produces many products and vaccines for domestic pets, farm animals and wildlife. Merial has about 6,900 employees and is present in more than 150 countries in the world. [4]
Pages in category "Drugs developed by Boehringer Ingelheim" The following 30 pages are in this category, out of 30 total. This list may not reflect recent changes. A.
(Reuters) - Boehringer Ingelheim will reduce out-of-pocket costs for the company's inhaler products for a chronic lung disease and asthma to $35 per month starting June 1, the German drugmaker ...
3 Largest selling pharmaceutical products of 2015. 4 Best selling pharmaceuticals of 2013. ... Boehringer Ingelheim, Lilly Icos: Oral anticoagulant: Oct-2010: Mon ...
And Boehringer Ingelheim is making it available to all Americans, regardless of insurance status," Gemmell said. Cyltezo will sell for $550, a 92% discount from the Humira list price of about $7,000.
Boehringer is a FDA-registered medical device company located in Phoenixville, PA founded by Jack Boehringer in 1972. The company initially released a line of anesthesia and respiratory care instruments, followed by suction regulators and autologous blood transfusion products.
Respimat, also known as Respimat Soft Mist Inhaler, is a drug delivery device used for the treatment of asthma, chronic obstructive pulmonary disease (COPD), and other respiratory conditions.